A Case of Fibrolamellar Hepatocellular Carcinoma in Which Tumor Control Was Achieved by Re‐Administering Atezolizumab and Bevacizumab
Combination therapy with atezolizumab, bevacizumab, and radiation therapy may be an option for the treatment of FL-HCC.
Authors
- Yoriaki Komeda (ORCID: https://orcid.org/0000-0002-0068-8461)
- Satoru Hagiwara (ORCID: https://orcid.org/0000-0002-3412-4701)
- Masatoshi Kudo (ORCID: https://orcid.org/0000-0002-4102-3474)
- Naoya Omaru
- Takuya Matsubara (ORCID: https://orcid.org/0000-0001-8869-7874)
- Kazuomi Ueshima (ORCID: https://orcid.org/0000-0002-7577-5789)
- Naoshi Nishida (ORCID: https://orcid.org/0000-0001-6581-7896)
- Akihiro Yoshida (ORCID: https://orcid.org/0000-0003-0977-2632)
- Itsuki Oda
- Tomoki Yamamoto
Institutions
- Kindai University (JP)
Publication Details
- Journal
- Cancer Reports
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/cnr2.70090
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.74